These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11032911)

  • 1. Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex.
    Ghee M; Fournier A; Mallet J
    J Neurochem; 2000 Nov; 75(5):2221-4. PubMed ID: 11032911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
    Kaplan B; Ratner V; Haas E
    J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent neuropathology of parkinsonian syndromes].
    Duyckaerts C; Verny M; Hauw JJ
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Ancolio K; Alves da Costa C; Uéda K; Checler F
    Neurosci Lett; 2000 May; 285(2):79-82. PubMed ID: 10793231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
    J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.
    Zhou W; Hurlbert MS; Schaack J; Prasad KN; Freed CR
    Brain Res; 2000 Jun; 866(1-2):33-43. PubMed ID: 10825478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.
    Stefanis L; Larsen KE; Rideout HJ; Sulzer D; Greene LA
    J Neurosci; 2001 Dec; 21(24):9549-60. PubMed ID: 11739566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.
    Cole NB; Murphy DD; Grider T; Rueter S; Brasaemle D; Nussbaum RL
    J Biol Chem; 2002 Feb; 277(8):6344-52. PubMed ID: 11744721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
    Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
    Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
    J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of rat brain using the Synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies.
    Andringa G; Du F; Chase TN; Bennett MC
    J Neuropathol Exp Neurol; 2003 Oct; 62(10):1060-75. PubMed ID: 14575241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein forms a complex with transcription factor Elk-1.
    Iwata A; Miura S; Kanazawa I; Sawada M; Nukina N
    J Neurochem; 2001 Apr; 77(1):239-52. PubMed ID: 11279280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines.
    Baptista MJ; O'Farrell C; Daya S; Ahmad R; Miller DW; Hardy J; Farrer MJ; Cookson MR
    J Neurochem; 2003 May; 85(4):957-68. PubMed ID: 12716427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.